139 related articles for article (PubMed ID: 9085047)
1. Muscarinic m4 receptor activation by some atypical antipsychotic drugs.
Zeng XP; Le F; Richelson E
Eur J Pharmacol; 1997 Mar; 321(3):349-54. PubMed ID: 9085047
[TBL] [Abstract][Full Text] [Related]
2. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
3. Clozapine interaction with the M2 and M4 subtypes of muscarinic receptors.
Michal P; Lysíková M; El-Fakahany EE; Tucek S
Eur J Pharmacol; 1999 Jul; 376(1-2):119-25. PubMed ID: 10440097
[TBL] [Abstract][Full Text] [Related]
4. Clozapine is a potent and selective muscarinic M4 receptor agonist.
Zorn SH; Jones SB; Ward KM; Liston DR
Eur J Pharmacol; 1994 Nov; 269(3):R1-2. PubMed ID: 7895765
[TBL] [Abstract][Full Text] [Related]
5. Mixed agonist-antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells.
Olianas MC; Maullu C; Onali P
Neuropsychopharmacology; 1999 Mar; 20(3):263-70. PubMed ID: 10063486
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic m1 receptor-stimulated adenylate cyclase activity in Chinese hamster ovary cells is mediated by Gs alpha and is not a consequence of phosphoinositidase C activation.
Burford NT; Nahorski SR
Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):883-8. PubMed ID: 8645172
[TBL] [Abstract][Full Text] [Related]
7. The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions?
Davies MA; Compton-Toth BA; Hufeisen SJ; Meltzer HY; Roth BL
Psychopharmacology (Berl); 2005 Apr; 178(4):451-60. PubMed ID: 15765260
[TBL] [Abstract][Full Text] [Related]
8. Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.
Herrick-Davis K; Grinde E; Teitler M
J Pharmacol Exp Ther; 2000 Oct; 295(1):226-32. PubMed ID: 10991983
[TBL] [Abstract][Full Text] [Related]
9. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG
Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic neuroleptic treatment on central and peripheral muscarinic receptors.
Cawley TA; Shickley TJ; Ruggieri MR; Luthin GR
J Pharmacol Exp Ther; 1993 Oct; 267(1):134-9. PubMed ID: 7901388
[TBL] [Abstract][Full Text] [Related]
11. M1 muscarinic receptors contribute to, whereas M4 receptors inhibit, dopamine D1 receptor-induced [3H]-cyclic AMP accumulation in rat striatal slices.
Sánchez-Lemus E; Arias-Montaño JA
Neurochem Res; 2006 Apr; 31(4):555-61. PubMed ID: 16758365
[TBL] [Abstract][Full Text] [Related]
12. Effects of recent and reference antipsychotic agents at human dopamine D2 and D3 receptor signaling in Chinese hamster ovary cells.
Vanhauwe JF; Ercken M; van de Wiel D; Jurzak M; Leysen JE
Psychopharmacology (Berl); 2000 Jul; 150(4):383-90. PubMed ID: 10958079
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic mechanisms of antipsychotic atypicality.
Bymaster FP; Felder CC; Tzavara E; Nomikos GG; Calligaro DO; Mckinzie DL
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1125-43. PubMed ID: 14642972
[TBL] [Abstract][Full Text] [Related]
14. Rat striatal muscarinic receptors coupled to the inhibition of adenylyl cyclase activity: potent block by the selective m4 ligand muscarinic toxin 3 (MT3).
Olianas MC; Adem A; Karlsson E; Onali P
Br J Pharmacol; 1996 May; 118(2):283-8. PubMed ID: 8735628
[TBL] [Abstract][Full Text] [Related]
15. Use of antimuscarinic toxins to facilitate studies of striatal m4 muscarinic receptors.
Purkerson SL; Potter LT
J Pharmacol Exp Ther; 1998 Feb; 284(2):707-13. PubMed ID: 9454818
[TBL] [Abstract][Full Text] [Related]
16. The role of muscarinic receptor antagonism in antipsychotic-induced hippocampal acetylcholine release.
Johnson DE; Nedza FM; Spracklin DK; Ward KM; Schmidt AW; Iredale PA; Godek DM; Rollema H
Eur J Pharmacol; 2005 Jan; 506(3):209-19. PubMed ID: 15627430
[TBL] [Abstract][Full Text] [Related]
17. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
McKinney M; Miller JH; Gibson VA; Nickelson L; Aksoy S
Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002
[TBL] [Abstract][Full Text] [Related]
18. Constitutive activity of the M1-M4 subtypes of muscarinic receptors in transfected CHO cells and of muscarinic receptors in the heart cells revealed by negative antagonists.
Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
FEBS Lett; 1995 Dec; 377(2):275-9. PubMed ID: 8543067
[TBL] [Abstract][Full Text] [Related]
19. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells.
Bolden C; Cusack B; Richelson E
J Pharmacol Exp Ther; 1992 Feb; 260(2):576-80. PubMed ID: 1346637
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment with antipsychotics does not alter the phosphoinositide response to muscarinic or D2 dopaminergic agonists in rat striatum.
Rubinstein JE; Hitzemann RJ; Ashby CR; Wang RY
Brain Res; 1989 Sep; 496(1-2):385-8. PubMed ID: 2572294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
